study_id,year,design,effect_type,effect_point,ci_low,ci_high,n_treat,n_ctrl,risk_of_bias,doi,journal_id,outcome,population,adverse_events,duration_weeks
MENT-MYO-IN_01,2016,randomized controlled trial,SMD,-0.3050,-0.4494,-0.1606,56,58,mixed,10.1234/ment-myo-in-01,mental_health_journal,panic_disorder,Adults with panic disorder concerns,Transient headache,8
MENT-MYO-IN_02,2017,randomized controlled trial,SMD,-0.3501,-0.5085,-0.1917,60,61,low,10.1234/ment-myo-in-02,mental_health_journal,panic_disorder,Adults with panic disorder concerns,None reported,9
MENT-MYO-IN_03,2018,randomized controlled trial,SMD,-0.4366,-0.5631,-0.3102,64,64,some concerns,10.1234/ment-myo-in-03,mental_health_journal,panic_disorder,Adults with panic disorder concerns,Mild GI discomfort,10
